国际妇产科学杂志 ›› 2021, Vol. 48 ›› Issue (3): 281-285.doi: 10.12280/gjfckx.20200799
收稿日期:
2020-08-27
出版日期:
2021-06-15
发布日期:
2021-06-25
通讯作者:
王琳
E-mail:wang930208@163.com
Received:
2020-08-27
Published:
2021-06-15
Online:
2021-06-25
Contact:
WANG Lin
E-mail:wang930208@163.com
摘要:
子宫内膜异位症(EMs)是一种常见且影响广大育龄期女性的妇科良性疾病,该病的早期诊断和治疗是目前临床工作中亟需解决的难题。EMs有3种公认的病理类型,分别是腹膜型、卵巢型及深部浸润型。然而不论哪种病理类型,疼痛都是EMs患者最为突出的临床表现,包括经期腹痛、慢性盆腔痛及性交痛等不适,严重影响女性的身心健康,并增加经济负担。脑源性神经营养因子(BDNF)是神经营养蛋白家族的成员之一,不仅广泛分布于中枢和外周神经系统内,且在女性生殖系统中的分布范围也较广,在炎症反应、肿瘤的发生发展、促进神经血管生成等多种病理生理学过程中发挥重要作用。BDNF同时也是各种慢性疾病疼痛形成和维持的重要调节因子,在EMs患者的血清及组织中已发现其明显高表达,逐渐成为EMs研究的热点。
李金铭, 王琳. 脑源性神经营养因子在子宫内膜异位症及其相关疼痛中的研究进展[J]. 国际妇产科学杂志, 2021, 48(3): 281-285.
LI Jin-ming, WANG Lin. Research Progress of BDNF in Endometriosis and Related Pain[J]. Journal of International Obstetrics and Gynecology, 2021, 48(3): 281-285.
[1] |
Zondervan KT, Becker CM, Missmer SA. Endometriosis[J]. N Engl J Med, 2020,382(13):1244-1256. doi: 10.1056/NEJMra1810764.
doi: 10.1056/NEJMra1810764 |
[2] |
Sieberg CB, Lunde CE, Borsook D. Endometriosis and pain in the adolescent- striking early to limit suffering: A narrative review[J]. Neurosci Biobehav Rev, 2020,108:866-876. doi: 10.1016/j.neubiorev.2019.12.004.
doi: 10.1016/j.neubiorev.2019.12.004 |
[3] |
洪玮, 段华, 汪沙. 脑源性神经营养因子与受体在子宫内膜异位症发生发展及相关症状中作用的研究进展[J]. 中国计划生育和妇产科, 2017,9(3):27-30,38. doi: 10.3969/j.issn.1674-4020.2017. 03.06.
doi: 10.3969/j.issn.1674-4020.2017. 03.06 |
[4] |
Chapron C, Marcellin L, Borghese B, et al. Rethinking mechanisms, diagnosis and management of endometriosis[J]. Nat Rev Endocrinol, 2019,15(11):666-682. doi: 10.1038/s41574-019-0245-z.
doi: 10.1038/s41574-019-0245-z |
[5] |
Laganà AS, Vitale SG, Salmeri FM, et al. Unus pro omnibus, omnes pro uno: A novel, evidence-based, unifying theory for the pathogenesis of endometriosis[J]. Med Hypotheses, 2017,103:10-20. doi: 10.1016/j.mehy.2017.03.032.
doi: 10.1016/j.mehy.2017.03.032 |
[6] |
王亚楠, 陈秀娟, 李雪玲, 等. 子宫内膜干细胞研究进展[J]. 中华妇产科杂志, 2015,50(10):798-800. doi: 10.3760/cma.j.issn.0529-567x.2015.10.021.
doi: 10.3760/cma.j.issn.0529-567x.2015.10.021 |
[7] |
Gajbhiye R, McKinnon B, Mortlock S, et al. Genetic Variation at Chromosome 2q13 and Its Potential Influence on Endometriosis Susceptibility Through Effects on the IL-1 Family[J]. Reprod Sci, 2018,25(9):1307-1317. doi: 10.1177/1933719118768688.
doi: 10.1177/1933719118768688 pmid: 29669463 |
[8] |
McKinnon BD, Bertschi D, Bersinger NA, et al. Inflammation and nerve fiber interaction in endometriotic pain[J]. Trends Endocrinol Metab, 2015,26(1):1-10. doi: 10.1016/j.tem.2014.10.003.
doi: 10.1016/j.tem.2014.10.003 |
[9] |
Wei Y, Liang Y, Lin H, et al. Autonomic nervous system and inflammation interaction in endometriosis-associated pain[J]. J Neuroinflammation, 2020,17(1):80. doi: 10.1186/s12974-020-01752-1.
doi: 10.1186/s12974-020-01752-1 |
[10] |
Chen P, Wang DB, Liang YM. Evaluation of estrogen in endometriosis patients: Regulation of GATA-3 in endometrial cells and effects on Th2 cytokines[J]. J Obstet Gynaecol Res, 2016,42(6):669-677. doi: 10.1111/jog.12957.
doi: 10.1111/jog.12957 |
[11] |
Liang Y, Xie H, Wu J, et al. Villainous role of estrogen in macrophage-nerve interaction in endometriosis[J]. Reprod Biol Endocrinol, 2018,16(1):122. doi: 10.1186/s12958-018-0441-z.
doi: 10.1186/s12958-018-0441-z |
[12] |
Ahn SH, Khalaj K, Young SL, et al. Immune-inflammation gene signatures in endometriosis patients[J]. Fertil Steril, 2016, 106(6):1420-1431.e7. doi: 10.1016/j.fertnstert.2016.07.005.
doi: 10.1016/j.fertnstert.2016.07.005 |
[13] |
Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain[J]. EMBO J, 1982,1(5):549-553.
pmid: 7188352 |
[14] |
Nijs J, Meeus M, Versijpt J, et al. Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?[J]. Expert Opin Ther Targets, 2015,19(4):565-576. doi: 10.1517/14728222.2014.994506.
doi: 10.1517/14728222.2014.994506 |
[15] |
Zanin JP, Unsain N, Anastasia A. Growth factors and hormones pro-peptides: the unexpected adventures of the BDNF prodomain[J]. J Neurochem, 2017,141(3):330-340. doi: 10.1111/jnc.13993.
doi: 10.1111/jnc.13993 |
[16] |
Lima Giacobbo B, Doorduin J, Klein HC, et al. Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation[J]. Mol Neurobiol, 2019,56(5):3295-3312. doi: 10.1007/s12035-018-1283-6.
doi: 10.1007/s12035-018-1283-6 |
[17] |
Amadio P, Porro B, Sandrini L, et al. Patho- physiological role of BDNF in fibrin clotting[J]. Sci Rep, 2019,9(1):389. doi: 10.1038/s41598-018-37117-1.
doi: 10.1038/s41598-018-37117-1 |
[18] |
Chacón-Fernández P, Säuberli K, Colzani M, et al. Brain-derived Neurotrophic Factor in Megakaryocytes[J]. J Biol Chem, 2016,291(19):9872-9881. doi: 10.1074/jbc.M116.720029.
doi: 10.1074/jbc.M116.720029 |
[19] |
Wessels JM, Kay VR, Leyland NA, et al. Assessing brain-derived neurotrophic factor as a novel clinical marker of endometriosis[J]. Fertil Steril, 2016, 105(1):119-128.e1-5. doi: 10.1016/j.fertnstert.2015.09.003.
doi: 10.1016/j.fertnstert.2015.09.003 |
[20] |
Dong F, Zhang Q, Kong W, et al. Regulation of endometrial cell proliferation by estrogen-induced BDNF signaling pathway[J]. Gynecol Endocrinol, 2017,33(6):485-489. doi: 10.1080/09513590. 2017.1295439.
doi: 10.1080/09513590. 2017.1295439 |
[21] |
Santulli P, Marcellin L, Tosti C, et al. MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis?[J]. Expert Opin Ther Targets, 2015,19(11):1465-1483. doi: 10.1517/14728222.2015.1090974.
doi: 10.1517/14728222.2015.1090974 |
[22] |
Bai H, Li H, Li W, et al. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines[J]. Oncotarget, 2015,6(28):25520-25532. doi: 10.18632/oncotarget.4550.
doi: 10.18632/oncotarget.4550 |
[23] |
Serra-Millàs M. Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?[J]. World J Psychiatry, 2016,6(1):84-101. doi: 10.5498/wjp.v6.i1.84.
doi: 10.5498/wjp.v6.i1.84 pmid: 27014600 |
[24] |
Pius-Sadowska E, Machaliński B. BDNF-A key player in cardiovascular system[J]. J Mol Cell Cardiol, 2017,110:54-60. doi: 10.1016/j.yjmcc.2017.07.007.
doi: 10.1016/j.yjmcc.2017.07.007 |
[25] |
Meng L, Liu B, Ji R, et al. Targeting the BDNF/TrkB pathway for the treatment of tumors[J]. Oncol Lett, 2019,17(2):2031-2039. doi: 10.3892/ol.2018.9854.
doi: 10.3892/ol.2018.9854 |
[26] |
洪玮, 段华, 汪沙, 等. BDNF及TrKB在子宫内膜异位症在位内膜和异位病灶组织中的表达及意义[J]. 中国计划生育和妇产科, 2018,10(3):32-36. doi: 10.3969/j.issn.1674-4020.2018.03.10.
doi: 10.3969/j.issn.1674-4020.2018.03.10 |
[27] |
Falcone T, Flyckt R. Clinical Management of Endometriosis[J]. Obstet Gynecol, 2018,131(3):557-571. doi: 10.1097/AOG.0000000000002469.
doi: 10.1097/AOG.0000000000002469 |
[28] |
Soliman AM, Taylor HS, Bonafede M, et al. Incremental direct and indirect cost burden attributed to endometriosis surgeries in the United States[J]. Fertil Steril, 2017,107(5):1181-1190.e2. doi: 10.1016/j.fertnstert.2017.03.020.
doi: 10.1016/j.fertnstert.2017.03.020 |
[29] |
Kobayashi H, Yamada Y, Morioka S, et al. Mechanism of pain generation for endometriosis-associated pelvic pain[J]. Arch Gynecol Obstet, 2014,289(1):13-21. doi: 10.1007/s00404-013-3049-8.
doi: 10.1007/s00404-013-3049-8 |
[30] |
Ding S, Zhu L, Tian Y, et al. P2X3 receptor involvement in endometriosis pain via ERK signaling pathway[J]. PLoS One, 2017,12(9):e0184647. doi: 10.1371/journal.pone.0184647.
doi: 10.1371/journal.pone.0184647 |
[31] |
Bohonyi N, Pohóczky K, Szalontai B, et al. Local upregulation of transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1 ion channels in rectosigmoid deep infiltrating endometriosis[J]. Mol Pain, 2017,13:1744806917705564. doi: 10.1177/ 1744806917705564.
doi: 10.1177/ 1744806917705564 |
[32] |
McAllister SL, Giourgas BK, Faircloth EK, et al. Prostaglandin levels, vaginal innervation, and cyst innervation as peripheral contributors to endometriosis-associated vaginal hyperalgesia in rodents[J]. Mol Cell Endocrinol, 2016,437:120-129. doi: 10.1016/j.mce.2016.08.017.
doi: 10.1016/j.mce.2016.08.017 |
[33] |
Yan D, Liu X, Guo SW. Nerve fibers and endometriotic lesions: partners in crime in inflicting pains in women with endometriosis[J]. Eur J Obstet Gynecol Reprod Biol, 2017,209:14-24. doi: 10.1016/j.ejogrb.2016.06.017.
doi: 10.1016/j.ejogrb.2016.06.017 |
[34] |
Laganà AS, La Rosa VL, Rapisarda A, et al. Anxiety and depression in patients with endometriosis: impact and management challenges[J]. Int J Womens Health, 2017,9:323-330. doi: 10.2147/IJWH.S119729.
doi: 10.2147/IJWH.S119729 |
[35] |
As-Sanie S, Kim J, Schmidt-Wilcke T, et al. Functional Connectivity is Associated With Altered Brain Chemistry in Women With Endometriosis-Associated Chronic Pelvic Pain[J]. J Pain, 2016,17(1):1-13. doi: 10.1016/j.jpain.2015.09.008.
doi: 10.1016/j.jpain.2015.09.008 pmid: 26456676 |
[36] |
Sikandar S, Minett MS, Millet Q, et al. Brain-derived neurotrophic factor derived from sensory neurons plays a critical role in chronic pain[J]. Brain, 2018,141(4):1028-1039. doi: 10.1093/brain/awy009.
doi: 10.1093/brain/awy009 pmid: 29394316 |
[37] |
Ding S, Zhu T, Tian Y, et al. Role of Brain-Derived Neurotrophic Factor in Endometriosis Pain[J]. Reprod Sci, 2018,25(7):1045-1057. doi: 10.1177/1933719117732161.
doi: 10.1177/1933719117732161 |
[38] |
Zheng P, Zhang W, Leng J, et al. Research on central sensitization of endometriosis-associated pain: a systematic review of the literature[J]. J Pain Res, 2019,12:1447-1456. doi: 10.2147/JPR.S197667.
doi: 10.2147/JPR.S197667 pmid: 31190954 |
[39] | Yu X, Ren H, Liu T, et al. Expression and significance of ERβ and TrkB in endometriosis[J]. Clin Exp Obstet Gynecol, 2016,43(1):75-81. |
[40] |
Stefani LC, Leite FM, da Graça L Tarragó M, et al. BDNF and serum S100B levels according the spectrum of structural pathology in chronic pain patients[J]. Neurosci Lett, 2019,706:105-109. doi: 10.1016/j.neulet.2019.05.021.
doi: 10.1016/j.neulet.2019.05.021 |
[41] |
López-Pérez AE, Nurgali K, Abalo R. Painful neurotrophins and their role in visceral pain[J]. Behav Pharmacol, 2018,29(2 and 3-Spec Issue):120-139. doi: 10.1097/FBP.0000000000000386.
doi: 10.1097/FBP.0000000000000386 pmid: 29543647 |
[42] |
Qin X, Liu Y, Feng Y, et al. Ginsenoside Rf alleviates dysmenorrhea and inflammation through the BDNF-TrkB-CREB pathway in a rat model of endometriosis[J]. Food Funct, 2019,10(1):244-249. doi: 10.1039/c8fo01839a.
doi: 10.1039/c8fo01839a |
[1] | 曹秀蓉, 周文柏, 范香, 王逸斐, 朱鹏峰. 单细胞RNA测序解析子宫内膜异位症血管生成机制[J]. 国际妇产科学杂志, 2025, 52(2): 199-205. |
[2] | 殷婷, 丛慧芳. 子宫内膜异位症与痛觉敏化的免疫学研究进展[J]. 国际妇产科学杂志, 2025, 52(2): 206-210. |
[3] | 江爱美, 张信美. 腹壁子宫内膜异位症的治疗进展[J]. 国际妇产科学杂志, 2025, 52(2): 211-216. |
[4] | 张云凤, 张宛玥, 卢悦, 王阳阳, 井佳雨, 牟婧祎, 王悦. ARID1A与PIK3CA突变在卵巢子宫内膜异位症恶变中的研究进展[J]. 国际妇产科学杂志, 2025, 52(1): 19-22. |
[5] | 石百超, 王宇, 常惠, 卢凤娟, 关木馨, 余健楠, 吴效科. 中药及天然产物改善子宫内膜异位症的作用机制[J]. 国际妇产科学杂志, 2025, 52(1): 66-71. |
[6] | 杨丽, 杨静, 叶尔登切切克, 韩锐, 腊晓琳. B细胞淋巴瘤6对HTR-8/SVneo滋养细胞增殖、凋亡、侵袭和迁移的影响[J]. 国际妇产科学杂志, 2024, 51(6): 659-663. |
[7] | 郭希, 刘思敏, 魏佳, 杨永秀. 卵巢及输卵管子宫内膜异位症恶变为透明细胞癌一例[J]. 国际妇产科学杂志, 2024, 51(6): 680-683. |
[8] | 高明周, 高冬梅, 马凤君, 张轲鑫, 张浩. 从雌激素波动视角探讨经前烦躁障碍症抑郁-疼痛发生基础研究进展[J]. 国际妇产科学杂志, 2024, 51(6): 703-706. |
[9] | 张艳, 张意茗. 子宫腺肌病合并卵巢子宫内膜异位囊肿取卵术后并发盆腔脓肿一例[J]. 国际妇产科学杂志, 2024, 51(6): 717-720. |
[10] | 李慧敏, 胡雅莉, 张森淮, 马晓梅, 许飞雪. 高强度聚焦超声技术在妇产科疾病中的应用进展[J]. 国际妇产科学杂志, 2024, 51(5): 486-491. |
[11] | 郭希, 魏佳, 杨永秀. 导致子宫内膜疾病的激素通路及调节因素[J]. 国际妇产科学杂志, 2024, 51(4): 395-400. |
[12] | 孙佳凡, 徐炜, 朱姝, 王秀丽. 地诺孕素对子宫内膜异位症病灶体积的影响[J]. 国际妇产科学杂志, 2024, 51(3): 284-289. |
[13] | 许阡, 段华, 汪沙, 安圆圆. 宫颈子宫内膜异位症84例临床病例分析[J]. 国际妇产科学杂志, 2024, 51(3): 302-305. |
[14] | 虞梁, 袁琳, 孟黄洋, 杨雨琴, 赵明睿, 张林, 程文俊. 基于病例报道腹壁子宫内膜异位症透明细胞癌变相关预后因素分析[J]. 国际妇产科学杂志, 2024, 51(2): 220-227. |
[15] | 张玮玥, 杨静, 季佳楠, 罗成燕. 腹壁子宫内膜异位症相关性透明细胞癌的诊治进展[J]. 国际妇产科学杂志, 2024, 51(1): 60-65. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||